ATR Price Prediction Next Week
Based on the provided data and recent market activity, here's the analysis and price prediction for ATR (AptarGroup) for the next trading week:
Technical Analysis
- RSI (14) at 36.90 indicates the stock is approaching oversold territory
- MACD shows bearish momentum with -3.47 and a small negative histogram of -0.08
- Stock is trading below its 20-day SMA (151.05) and 60-day SMA (158.85), indicating short-term bearish trend
- Bollinger Bands show price near the lower band, suggesting potential oversold conditions
Recent Performance & News
- Stock closed at $140.13 on Friday, showing weakness in recent sessions
- Q4 earnings beat estimates with EPS of $1.52 vs $1.26 expected
- Several analysts maintained bullish ratings while lowering price targets
- Company faces near-term headwinds but maintains strong market position in dispensing systems
Price Targets for Next Week
- Support levels:
- S1: $140.58 (Fibonacci)
- S2: $136.34 (Fibonacci)
- Resistance levels:
- R1: $154.31 (Fibonacci)
- R2: $158.55 (Fibonacci)
Prediction Based on technical indicators and recent price action, ATR is likely to trade between $138-$145 next week. The stock appears oversold but lacks immediate catalysts for a strong rebound.
Trading Recommendation SELL with target entry at current market price ($145.60). Set stop loss at $148.50 and initial profit target at $138.00. The bearish momentum and technical weakness suggest further downside potential in the short term.
ATR Similar Chart Price Prediction
The price of ATR is predicted to go up 13.16%, based on the high correlation periods with PRG. The similarity of these two price pattern on the periods is 98.25%.
ATR
PRG
Up: 13.16%Similarity: 98.25%
ATR Revenue Forecast
ATR EPS Forecast
ATR FAQs
What is bull’s view on ATR?
What is bear's view on ATR?
What is ATR revenue forecast for next quarter？
What is ATR eps forecast for next quarter？
ATR VS S&P500
Aptar's strong relationships with multinational customers will help the firm expand into emerging markets such as Asia and Latin America.
The COVID-19 pandemic and the explosive growth in GLP-1 drugs for obesity has given Aptar the opportunity to add coated injectable packaging components to drug files for customers looking to dual-source.
Aptar intends to develop a services-only division to monetize the testing and trial stages of the development process, which could further entrench Aptar's sticky customer base.
ATR Analyst's Forecast
Gabe Hajde
Wells Fargo
Buy
2025-02-10
Price Target
$180 → $170
Upside
+19.37%
Wells Fargo lowered the firm's price target on AptarGroup to $170 from $180 and keeps an Overweight rating on the shares. The firm notes AptarGroup's shares "took a beating" on Friday, owing to comments on tax, FX being a 2025 EPS headwind and a quarterly slowdown in Pharma organic growth. However, underlying performance "remains superb" with Well's long-term thesis unchanged, the firm adds.
Ghansham Panjabi
Baird
Buy
2025-02-10
Price Target
$185 → $160
Upside
+12.35%
Matt Roberts
Raymond James
Buy
2025-01-07
Price Target
$200
Upside
+30.9%
